MG1109

· Green Cross Corporation

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MG1109, covering 2014-11-21 to 2015-07-03. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Study to Evaluate the Immunogenicity and Safety of MG1109 in Healthy Adult Volunteers [Phase 3]